Skip to main contentSkip to breadcrumbsSkip to sub navSkip to doormat

Johannes Zuber

The genetic complexity, heterogeneity and plasticity of human cancers pose daunting challenges for the development of effective targeted therapies. New functional genetic tools such as CRISPR/Cas9, RNAi and targeted protein degradation have fundamentally changed the way we can approach this problem. Our lab develops and employs these tools to systematically identify and mechanistically study key regulators and dependencies in genetically engineered cancer models and tumor-associated immune cells.

Group Members

Ines AMORIM MONTEIRO BARBOSA
Aleksandra BUNDALO
Master Student
Melanie Talata DE ALMEIDA
PhD Student
Anja EBERT
Research Associate
Michaela FELLNER
Research Assistant
Matthias HINTERNDORFER
PhD Student
Robert Wolfgang KALIS
Bernadette MÖDL
Master Student
Matthias MUHAR
PhD Student
Sarah Christine RIESER
PhD Student
Stefanie RUHLAND
Master Student
Markus SCHÄFER
Postdoc
Johannes SCHMÖLLERL
Monika STEININGER
PhD Student
Martina WEIßENBÖCK
Research Assistant
Johannes ZUBER
Group Leader